OXSTONE M&A/TAKEOVER TRADE IDEAS

30-Oct-2010

I like this.

By

An eternal optimist, Liu-Yue built two social enterprises to help make the world a better place. Liu-Yue co-founded Oxstones Investment Club a searchable content platform and business tools for knowledge sharing and financial education. Oxstones.com also provides investors with direct access to U.S. commercial real estate opportunities and other alternative investments. In addition, Liu-Yue also co-founded Cute Brands a cause-oriented character brand management and brand licensing company that creates social awareness on global issues and societal challenges through character creations. Prior to his entrepreneurial endeavors, Liu-Yue worked as an Executive Associate at M&T Bank in the Structured Real Estate Finance Group where he worked with senior management on multiple bank-wide risk management projects. He also had a dual role as a commercial banker advising UHNWIs and family offices on investments, credit, and banking needs while focused on residential CRE, infrastructure development, and affordable housing projects. Prior to M&T, he held a number of positions in Latin American equities and bonds investment groups at SBC Warburg Dillon Read (Swiss Bank), OFFITBANK (the wealth management division of Wachovia Bank), and in small cap equities at Steinberg Priest Capital Management (family office). Liu-Yue has an MBA specializing in investment management and strategy from Georgetown University and a Bachelor of Science in Finance and Marketing from Stern School of Business at NYU. He also completed graduate studies in international management at the University of Oxford, Trinity College.







By Liu-Yue (Louie) Lam, Oxstones

YHOO, YAHOO – $16.49, 10/30/10, remember MSFT wanted to buy it in the $30’s?  Still has a great brand name, hidden international treasure asset – Alibaba, a China play on auctions a la Ebay and B2B ecommerce – global supply chain.

ELN, ELAN – $5.45, 10/30/10, still has a blockbuster multiple sclerosis drug – Tysabri.  Currently trading near multi-year lows.  Massive drug patent expiration from big pharma have pushed them to M&A in order to fill their product lines with acquisitions to replace revenues lost from generic competition. Potential take over target, maybe partner – Biogen or JNJ will close the deal.  Johnson & Johnson did buy a stake for $12  a few years ago.

AOL – $26.68, 10/30/10.  Still have that legendary brand name that must be worth something.  Has a nice collection of internet properties.  Relatively cheap valuation compared to peers in the industry.  Potential take over target from its larger peers to further consolidate mind share.

SNE, SONY – $33.84, 10/30/10.  Great brand name and international recognition.  Still makes great electronic products of high quality.  But missing the old legendary innovation for new products.  Maybe Apple can help ignite the old R&D by joining forces?  Sony is cheap in terms of valuation for a world class brand.  Currently trading near multi-year lows and below its book value for additional margin of safety for a high quality company.

*** Please kindly note, these are not recommendations and Oxstone Capital Management do not take any responsibility for the investment performance of the idea nor the execution of the ideas listed above.   The OXSTONE M&A / TAKE-OVER TRADE IDEAS List is simply Oxstones personal investment positions, and we are openly sharing our ideas and personal investments for the benefit of the Oxstones community.   Please remember to always protect your downside with proper risk management controls such as portfolio diversification, asset allocation, position sizing, and stop losses.  Please feel free to also write and share your best ideas for the benefit of the entire Oxstones investment community.

Kindest Regards,

Liu-Yue (Louie) Lam, Co-Founder, CEO, & Chief Investment Strategist


More IDEAS Coming Soon!

Please Check Regularly in   ‘OUR PORTFOLIO’ tab


Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*

Subscribe without commenting